Estimate Recalculated Nov 1, 2024 02:23PM EST
Jonathan C Fox does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include MyoKardia Inc, Eidos Therapeutics, Inc., and Edgewise Therapeutics, Inc..
Jonathan C Fox's CIK is 0001655016
2023 was Jonathan C Fox's most active year for acquiring shares with 3 total transactions. Jonathan C Fox's most active month to acquire stocks was the month of October. 2021 was Jonathan C Fox's most active year for disposing of shares, totalling 2 transactions. Jonathan C Fox's most active month to dispose stocks was the month of December. 2023 saw Jonathan C Fox paying a total of $100,958.16 for 76,711 shares, this is the most they've acquired in one year. In 2021 Jonathan C Fox cashed out on 450,467 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!